Search research articles
Contact Us
Filters
Showing results (141-150 of 204) with videos related to
Page
of 21
Sort By:
Experimental Hematology
|
November 4, 2019
Shared and Tissue-Specific Expression Signatures between Bone Marrow from Primary Myelofibrosis and Essential Thrombocythemia
Genta Ishikawa, Naoto Fujiwara, Hadassa Hirschfield, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 16, 2024
Clonal Hematopoiesis of Indeterminate Potential in Crohn's Disease and Ulcerative Colitis
Myvizhi Esai Selvan, Daniel I Nathan, Daniela Guisado, et al.
Blood
|
January 27, 2005
Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia
Damiano Rondelli, Giovanni Barosi, Andrea Bacigalupo, et al.
Inflammatory Bowel Diseases
|
January 6, 2025
Clonal Hematopoiesis of Indeterminate Potential in Crohn's Disease and Ulcerative Colitis
Myvizhi Esai Selvan, Daniel I Nathan, Daniela Guisado, et al.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
Inhibition of the EBF1-ITGB8 Axis in Bone Marrow Niche Ameliorates Hallmarks of Myelofibrosis
Lyudmila Tsurkan, Mélodie Douté, Nicholas Morchel, et al.
Leukemia & Lymphoma
|
May 18, 2026
Long term outcomes of idasanutlin therapy in hydroxyurea-refractory polycythemia vera patients
Megan Metzger, Julian A Waksal, Jayanshu Jain, et al.
Blood
|
March 1, 2011
The dominant negative β isoform of the glucocorticoid receptor is uniquely expressed in erythroid cells expanded from polycythemia vera patients
Lilian Varricchio, Elena Masselli, Elena Alfani, et al.
Experimental Hematology
|
May 18, 2004
Studies of the route of administration and role of conditioning with radiation on unrelated allogeneic mismatched mesenchymal stem cell engraftment in a nonhuman primate model
Nadim Mahmud, Wenxin Pang, Carrington Cobbs, et al.
Haematologica
|
July 2, 2013
Single agent bevacizumab for myelofibrosis: results of the Myeloproliferative Disorders Research Consortium Trial
Ruben A Mesa, Richard T Silver, Srdan Verstovsek, et al.
Frontiers in Oncology
|
April 8, 2022
The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the <i>Gata1</i> <sup>low</sup> Mice
Paola Verachi, Francesca Gobbo, Fabrizio Martelli, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 204) with videos related to
Sort By:
Page
of 21
Experimental Hematology
|
November 4, 2019
Shared and Tissue-Specific Expression Signatures between Bone Marrow from Primary Myelofibrosis and Essential Thrombocythemia
Genta Ishikawa, Naoto Fujiwara, Hadassa Hirschfield, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 16, 2024
Clonal Hematopoiesis of Indeterminate Potential in Crohn's Disease and Ulcerative Colitis
Myvizhi Esai Selvan, Daniel I Nathan, Daniela Guisado, et al.
Blood
|
January 27, 2005
Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia
Damiano Rondelli, Giovanni Barosi, Andrea Bacigalupo, et al.
Inflammatory Bowel Diseases
|
January 6, 2025
Clonal Hematopoiesis of Indeterminate Potential in Crohn's Disease and Ulcerative Colitis
Myvizhi Esai Selvan, Daniel I Nathan, Daniela Guisado, et al.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
Inhibition of the EBF1-ITGB8 Axis in Bone Marrow Niche Ameliorates Hallmarks of Myelofibrosis
Lyudmila Tsurkan, Mélodie Douté, Nicholas Morchel, et al.
Leukemia & Lymphoma
|
May 18, 2026
Long term outcomes of idasanutlin therapy in hydroxyurea-refractory polycythemia vera patients
Megan Metzger, Julian A Waksal, Jayanshu Jain, et al.
Blood
|
March 1, 2011
The dominant negative β isoform of the glucocorticoid receptor is uniquely expressed in erythroid cells expanded from polycythemia vera patients
Lilian Varricchio, Elena Masselli, Elena Alfani, et al.
Experimental Hematology
|
May 18, 2004
Studies of the route of administration and role of conditioning with radiation on unrelated allogeneic mismatched mesenchymal stem cell engraftment in a nonhuman primate model
Nadim Mahmud, Wenxin Pang, Carrington Cobbs, et al.
Haematologica
|
July 2, 2013
Single agent bevacizumab for myelofibrosis: results of the Myeloproliferative Disorders Research Consortium Trial
Ruben A Mesa, Richard T Silver, Srdan Verstovsek, et al.
Frontiers in Oncology
|
April 8, 2022
The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the <i>Gata1</i> <sup>low</sup> Mice
Paola Verachi, Francesca Gobbo, Fabrizio Martelli, et al.
Page
of 21